Article
Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study
Fecha
2020Registro en:
FOLSCHWEILLER, Nicolas et al. Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study. EClinicalMedicine, v. 23, n. 100353, p. 1-16, 2020.
2589-5370
10.1016/j.eclinm.2020.100353
Autor
Folschweiller, Nicolas
Teixeira, Julio
Joshi, Smita
Goldani, Luciano Z.
Supparatpinyo, Khuanchai
Basu, Partha
Chotpitayasunondh, Tawee
Chetchotisakd, Ploenchan
Ruxrungtham, Kiat
Roteli-Martins, Cecilia
Grinsztejn, Beatriz
Quintana, Silvana Maria
Kumarasamy, Nagalingeswaran
Poongulali, Selvamuthu
Kulkarni, Vinay
Lin, Lan
Datta, Sanjoy K.
Descamps, Dominique
Dodet, Monique
Dubin, Gary
Friel, Damien
Hezareh, Marjan
Karkada, Naveen
Meric Camilleri, Dorothee
Poncelet, Sylviane
Salaun, Bruno
Tavares-da-Silva, Fernanda
Thomas-Jooris, Florence
Struyf, Frank